Mutated EGFR-IN-1
Mutated EGFR-IN-1 (Osimertinib analog) (Intermediate 168) is an intermediate of the mutant EGFR inhibitor.
Product Specifications
CAS Number
1421372-66-8
Product Name Alternative
Osimertinib analog
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
EGFR
Type
Reference compound
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/mutated-egfr-in-1.html
Concentration
10mM
Purity
99.90
Solubility
DMSO : ≥ 75 mg/mL
Smiles
NC1=CC(NC2=NC=CC(C3=CN(C)C4=C3C=CC=C4)=N2)=C(OC)C=C1N(CCN(C)C)C
Molecular Formula
C25H31N7O
Molecular Weight
445.56
Precautions
H302, H315, H319, H335
References & Citations
[1]Patent WO 2013014448 A1. 2 - (2, 4, 5 - substituted -anilino) pyrimidine derivatives as egfr modulators useful for treating cancer
 .
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC401068 20 µg
Solute carrier family 22 member 5 (SLC22A5) (NM_003060) Human Over-expression Lysate
Sign In for Pricing
View Details 
60900 15 Preparations
Cell Culture Media Exosome Purification and RNA Isolation Maxi Kit
Sign In for Pricing
View Details 
PKSV030169 100 µg
Recombinant Enterovirus D68 (EV-D68) (strain Fermon) VP1 Protein (Fc Tag)
Sign In for Pricing
View Details